These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 16323970)

  • 1. Cardiovascular drug therapy in elderly patients: specific age-related pharmacokinetic, pharmacodynamic and therapeutic considerations.
    Mangoni AA
    Drugs Aging; 2005; 22(11):913-41. PubMed ID: 16323970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular pharmacology of aging.
    Podrazik PM; Schwartz JB
    Cardiol Clin; 1999 Feb; 17(1):17-34. PubMed ID: 10093763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular drug therapy in the elderly.
    Aronow WS; Frishman WH; Cheng-Lai A
    Heart Dis; 2000; 2(2):151-67. PubMed ID: 11728253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics in older adults: a review.
    Bowie MW; Slattum PW
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):263-303. PubMed ID: 17996666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of cardiovascular medications in the elderly.
    Ali Raza J; Movahed A
    Int J Cardiol; 2002 Oct; 85(2-3):203-15. PubMed ID: 12208585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic considerations relating to tacrolimus dosing in the elderly.
    Staatz CE; Tett SE
    Drugs Aging; 2005; 22(7):541-57. PubMed ID: 16038570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General anaesthesia in elderly patients with cardiovascular disorders: choice of anaesthetic agent.
    Das S; Forrest K; Howell S
    Drugs Aging; 2010 Apr; 27(4):265-82. PubMed ID: 20359259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiovascular pharmacotherapy in the aged].
    Baumhäkel M; Böhm M
    Internist (Berl); 2003 Aug; 44(8):943-50. PubMed ID: 14671808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic-pharmacodynamic crisis in the elderly.
    ElDesoky ES
    Am J Ther; 2007; 14(5):488-98. PubMed ID: 17890940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular drug therapy in the elderly.
    Aronow WS; Frishman WH; Cheng-Lai A
    Cardiol Rev; 2007; 15(4):195-215. PubMed ID: 17575484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy insight: how changes in renal function with increasing age affect cardiovascular drug prescribing.
    Wyatt CM; Kim MC; Winston JA
    Nat Clin Pract Cardiovasc Med; 2006 Feb; 3(2):102-9. PubMed ID: 16446779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender-specific implications for cardiovascular medication use in the elderly optimizing therapy for older women.
    Schwartz JB
    Cardiol Rev; 2003; 11(5):275-98. PubMed ID: 12943605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular drug therapy in women.
    Spencer AP; Wingate S
    J Cardiovasc Nurs; 2005; 20(6):408-17; quiz 418-9. PubMed ID: 16485625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic basis for altered drug action in the elderly.
    Roberts J; Tumer N
    Clin Geriatr Med; 1988 Feb; 4(1):127-49. PubMed ID: 3278786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC.
    Rosano GM; Lewis B; Agewall S; Wassmann S; Vitale C; Schmidt H; Drexel H; Patak A; Torp-Pedersen C; Kjeldsen KP; Tamargo J
    Eur Heart J; 2015 Oct; 36(40):2677-80. PubMed ID: 25948737
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers.
    Siest G; Marteau JB; Maumus S; Berrahmoune H; Jeannesson E; Samara A; Batt AM; Visvikis-Siest S
    Eur J Pharmacol; 2005 Dec; 527(1-3):1-22. PubMed ID: 16316654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiological drugs and the elderly].
    Grand A
    Ann Cardiol Angeiol (Paris); 1997; 46(7):461-8. PubMed ID: 9452781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered pharmacodynamics of cardiovascular drugs and their relation to altered pharmacokinetics in elderly patients.
    Abernethy DR
    Clin Geriatr Med; 1990 May; 6(2):285-92. PubMed ID: 2184924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related changes in pharmacodynamics: focus on drugs acting on central nervous and cardiovascular systems.
    Trifirò G; Spina E
    Curr Drug Metab; 2011 Sep; 12(7):611-20. PubMed ID: 21495972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications.
    Hämmerlein A; Derendorf H; Lowenthal DT
    Clin Pharmacokinet; 1998 Jul; 35(1):49-64. PubMed ID: 9673834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.